Therapeutic Asset Ratings
567 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Treosulfan
Hodgkins Lymphoma
Fred Hutchinson Cancer Center
P2
CCC
(48)
Treosulfan
Mantle Cell Lymphoma
Fred Hutchinson Cancer Center
P2
CCC
(48)
Anti-Steap1 Car T-Cells
Castration-Resistant Prostate Carcinoma
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
APAMISTAMAB-B10-ASTATINE AT-211
Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
APAMISTAMAB-B10-ASTATINE AT-211
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Imgn632
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Interleukin 18 (recombinant human mutein clone ST-067)
Follicular Lymphoma
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Interleukin 18 (recombinant human mutein clone ST-067)
High Grade B-Cell Lymphoma
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Interleukin 18 (recombinant human mutein clone ST-067)
Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Polyiclc
Metastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Quemliclustat
Urinary Bladder Cancer
Fred Hutchinson Cancer Center
P1/2
CCC
(48)
Rivogenlecleucel
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
P2/3
CCC
(48)
Dilanubicel
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
P2
CC
(47)
Cyclophosphamide
Prostate Carcinoma
Fred Hutchinson Cancer Center
P1
CC
(47)
Anti-Steap1 Car T-Cells
Prostate Cancer
Fred Hutchinson Cancer Center
P1/2
CC
(47)
APAMISTAMAB-B10-ASTATINE AT-211
Hematopoietic And Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center
P1/2
CC
(47)
APAMISTAMAB-B10-ASTATINE AT-211
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P1/2
CC
(47)
APAMISTAMAB-B10-ASTATINE AT-211
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Decitabine
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P1/2
CC
(47)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Unresectable Ureter Urothelial Carcinoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Interferon ?1 (human fibroblast protein moiety)
B-Cell Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Interferon ?1 (human fibroblast protein moiety)
B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Interferon ?1 (human fibroblast protein moiety)
Mantle Cell Lymphoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Interleukin 18 (recombinant human mutein clone ST-067)
Primary Mediastinal Large B-Cell Lymphoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Quemliclustat
Bladder Transitional Cell Carcinoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Showing 451 to 475 of 567 assets
Previous
Page 19 of 23
Next